By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Biohaven Pharma 

234 Church Street

New Haven  Connecticut  06510  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS



Key Statistics


Email:
Ownership: Public

Web Site: Biohaven
Employees:
Symbol: BHVN
 



Industry
Pharmaceutical






Company News
Biohaven (BHVN) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 5/15/2017 6:56:00 AM
Biohaven (BHVN)'s Trigriluzole Receives Fast Track Designation From U.S. FDA 5/15/2017 6:34:31 AM
Biohaven (BHVN) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 5/12/2017 7:55:52 AM
Portage Biotech's Holding In Biohaven (BHVN) 5/9/2017 10:54:42 AM
Biohaven (BHVN) Announces Pricing of its Initial Public Offering of Common Shares 5/4/2017 6:54:59 AM
Biohaven Eyes $100 Million IPO to Bankroll Trials of Shelved AstraZeneca PLC (AZN), Bristol-Myers Squibb (BMY) Drugs 4/10/2017 5:45:15 AM
Biohaven Closes Second Tranche Of Private Placement And Appoints Two New Directors To Board 3/8/2017 9:52:13 AM
Biohaven Closes Second Tranche Of Private Placement And Appoints Two New Directors To Board 3/7/2017 7:34:58 AM
Biohaven Enrolls First Patient In Pivotal Trial Of BHV-4157 In Patients With Hereditary Spinocerebellar Ataxia 12/22/2016 12:35:10 PM
Biohaven' BHV-0223 Is Granted Orphan Drug Designation In The Treatment Of Amyotrophic Lateral Sclerosis 12/9/2016 7:19:07 AM
12
//-->